PYXS
Pyxis Oncology
$1.98
+$0.14 (+7.61%)Oct 28, 2026
Key metrics
The numbers that frame PYXS today
- Market cap
- $165.15M
- Gross margin
- 78.4%
- EV / Sales
- 14.7
- ROIC
- -141.1%
- Div yield
- 0%
- Debt / equity
- 1.6
- 52wk Low
- $1.03
- 52wk High
- $5.55
Growth
Revenue and earnings trend for PYXS
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about PYXS
Is Pyxis Oncology a good buy?
Hold. Pyxis Oncology has excellent momentum, but poor quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Pyxis Oncology is selling at a very high price.
What is the market capitalization of PYXS?
Pyxis Oncology's market capitalization is $165.15M.
What is the 52-week high for PYXS stock?
The 52-week high for Pyxis Oncology is $5.55. The current close of $1.98 is 64.3% below that high.
What is the 52-week low for PYXS stock?
The 52-week low for Pyxis Oncology is $1.03. The current close of $1.98 is 92.2% above that low.
Does PYXS stock pay dividends?
Pyxis Oncology does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for PYXS?
Pyxis Oncology's Debt / Equity ratio is 1.56.